These observations are in agreement with previous studies, showing increased CD8 T cells and NK cell production of Th1-effector cytokines such as IFN-γ and/or TNF-α [28] and increased anti-tumor responses in patients with metastatic breast cancer treated with paclitaxel in combination with IMP321 [29]. This evidence concerns the gene CD8A and neoplasm.